Skip to main content

Table 4 Modeled ICURs for the UK (discounted, 3.5 %)

From: Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

Outcomes, 3.5 % discount

Mean value (95 % CI)

UK1

Cost per case averted

£282 (118; 538)

Cost per GP visit averted

£1,100 (456; 2,113)

Cost per ER visit averted

£35,568 (14,729; 68,327)

Cost per hospitalization averted

£23,929 (9,934; 45,494)

Cost per death averted

£117,428 (43,067; 246,342)

Cost per QALY gained

£7,989 (3,132; 16,318)

Cost per LY gained

£11,081 (4,135; 23,186)

UK2

Cost per case averted

£250 (105; 461)

Cost per GP visit averted

£979 (404; 1,821)

Cost per ER visit averted

£31,641 (13,069; 58,892)

Cost per hospitalization averted

£21,207 (8,909; 39,220)

Cost per death averted

£110,496 (42,719; 221,654)

Cost per QALY gained

£7,324 (2,937; 14,044)

Cost per LY gained

£10,364 (4,029; 20,588)

  1. Note: GP, general practitioner; ER, emergency room; QALY, quality-adjusted life year; LY, life year